594

POEM IN TYPE 3 ACHALASIA. IS A LONG MYOTOMY NECESSARY?

Date
May 19, 2024

Background: Type 3 achalasia patients are believed to require longer myotomies to address the spastic esophagus in addition to the non-relaxing sphincter. This has been espoused on recent guidelines that advocate POEM in preference to Heller in these patients. However, recent data suggest that a long myotomy may not be necessary (for example, similar success of POEM and Heller in type 3 patients in the European randomized trial and absence of correlation between myotomy length and POEM success in type 3 patients in a recent meta-analysis). We have also gradually come to this realization and, over the past decade, have progressively shortened our POEM myotomy length in type 3 patients. Careful patient follow-up did not indicate any deterioration in outcomes. We present a detailed analysis of our accumulated data. Methods: From our prospectively maintained database of POEM procedural data and outcomes we extracted all POEMs on type 3 patients with minimum follow-up of 2 years. We identified 124 such POEMs out of 787 POEMs performed from 10/2009 to 11/2021. Since our POEM myotomy in type 3 patients was shortened gradually over this period, in order to analyze the effect on POEM outcomes, we compared consecutive chronological groups. We divided the patients into 4 equal consecutive groups (31 patients per group). Baseline characteristics and outcomes were compared between the 4 groups. Results: Figure 1 demonstrates our progressive shortening of the POEM myotomy across the 4 groups (19cm, 16cm, 12cm, 9cm, p<0.001), mainly due to shortening of the esophageal myotomy (figure 2). There were no differences in baseline characteristics or clinical success with all groups having a median Eckardt score (ES) of zero. A trend towards higher clinical efficacy in the most recent groups was seen (at a less stringent alpha of 0.1) when assessed as % of patients with success (84%, 97%, 90%, 100%, p=0.075) or as % of patients with ES≥2 (19%, 9.7%, 6.5%, 0%, p=0.06). This trend is most likely due to the expected progressively shorter follow-up across the 4 groups (median follow-up in months: 92, 74, 59, 36, p<0.001) rather than superior efficacy of shorter vs longer myotomy. No significant differences in GERD symptoms, erosive esophagitis, length of stay and adverse events. There was a decrease in POEM procedure time consistent with growing operator experience. However, this occurred early on, in group 1 (87 min) with groups 2, 3 and 4 having similar procedure times (56, 55, 53 min). Conclusion: We present intriguing data from our large cohort of POEMs in type 3 achalasia patients that suggest that standard length myotomies may be non-inferior to long myotomies. These data should be confirmed in randomized trials.
Figure 1

Figure 1

Figure 2

Figure 2


Tracks

Related Products

Thumbnail for LONG TERM OUTCOMES OF SALVAGE POEM AFTER FAILED HELLER IN A LARGE US COHORT. COMPARISON OF OUTCOMES TO THOSE OF POEM IN TREATMENT NAIVE PATIENTS
LONG TERM OUTCOMES OF SALVAGE POEM AFTER FAILED HELLER IN A LARGE US COHORT. COMPARISON OF OUTCOMES TO THOSE OF POEM IN TREATMENT NAIVE PATIENTS
BACKGROUND: Heller myotomy (HM) is one of the most effective treatments for esophageal achalasia and has a five-year symptom free rate of 77-90%. However, failures do exist and the success rate tends to decrease with longer follow-up. The efficacy of traditional rescue treatments is limited…
Thumbnail for EXTRCORPOREAL ENDOSCOPIC SUBMUCOSAL DISSECTION FOR EN BLOC RESECTION OF ANAL SQUAMOUS NEOPLASM
EXTRCORPOREAL ENDOSCOPIC SUBMUCOSAL DISSECTION FOR EN BLOC RESECTION OF ANAL SQUAMOUS NEOPLASM
There are numerous small series and case reports of ESD for anal squamous lesions. However, the reported lesions did not extend beyond the anal canal and were removed by traditional ESD. We report the first case of extracorporeal ESD…